PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18495311-3	2008	The selective 5-HT1A agonists, 8-hydroxydipropylaminotetraline (8-OH-DPAT) and tandospirone, significantly attenuated haloperidol-induced bradykinesia in a dose-dependent manner.	8-Hydroxy-2-(di-n-propylamino)tetralin	64-73	5-hydroxytryptamine (serotonin) receptor 1A	Mus musculus	14-20	
18495311-4	2008	The alleviation of haloperidol-induced bradykinesia by 8-OH-DPAT was completely antagonized by WAY-100135 (a selective 5-HT1A antagonist), but was unaffected by cerebral 5-HT depletion with p-chlorophenylalanine (PCPA) treatment (300 mg/kg, i.p.	8-Hydroxy-2-(di-n-propylamino)tetralin	55-64	5-hydroxytryptamine (serotonin) receptor 1A	Mus musculus	119-125